{"id":"https://openalex.org/W2062373072","doi":"https://doi.org/10.1182/blood-2010-03-275800","title":"Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone","display_name":"Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone","alternate_titles":[],"publication_year":2010,"publication_date":"2010-07-14","ids":{"openalex":"https://openalex.org/W2062373072","doi":"https://doi.org/10.1182/blood-2010-03-275800","mag":"2062373072","pmid":"https://pubmed.ncbi.nlm.nih.gov/20628153"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2010-03-275800","doi":"https://doi.org/10.1182/blood-2010-03-275800","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2010-03-275800","pdf_url":"https://ashpublications.org/blood/article-pdf/116/19/3743/1489251/zh804510003743.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2062373072"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/116/19/3743/1489251/zh804510003743.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110474614","display_name":"Jean\u2010Luc Harousseau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jean-Luc Harousseau","raw_affiliation_strings":["Centre Ren\u00e9 Gauducheau, Nantes/St Herblain, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Ren\u00e9 Gauducheau, Nantes/St Herblain, France;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059967673","display_name":"Antonio Pierangelo Palumbo","orcid":"https://orcid.org/0000-0002-1763-6609","observed_orcids":["https://orcid.org/0000-0002-1763-6609"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Antonio Palumbo","raw_affiliation_strings":["Universita di Torino, Torino, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universita di Torino, Torino, Italy;","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043526996","display_name":"Paul Gerard Guy Richardson","orcid":"https://orcid.org/0000-0002-7426-8865","observed_orcids":["https://orcid.org/0000-0002-7426-8865"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul G. Richardson","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;","Dana-Farber Cancer Institute, Boston, MA#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA#TAB#","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082309872","display_name":"Rudolf Schlag","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rudolf Schlag","raw_affiliation_strings":["Praxisklinik Dr Schlag, W\u00fcrzburg, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Praxisklinik Dr Schlag, W\u00fcrzburg, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033573338","display_name":"Meletios Athanasios Dimopoulos","orcid":"https://orcid.org/0000-0001-8990-3254","observed_orcids":["https://orcid.org/0000-0001-8990-3254"]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]}],"countries":["GR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Meletios A. Dimopoulos","raw_affiliation_strings":["University of Athens, School of Medicine, Athens, Greece;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Athens, School of Medicine, Athens, Greece;","institution_ids":["https://openalex.org/I200777214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058355502","display_name":"Ofer Shpilberg","orcid":"https://orcid.org/0000-0003-4463-7647","observed_orcids":["https://orcid.org/0000-0003-4463-7647"]},"institutions":[{"id":"https://openalex.org/I2800389475","display_name":"Rabin Medical Center","ror":"https://ror.org/01vjtf564","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2800389475","https://openalex.org/I64767286"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ofer Shpilberg","raw_affiliation_strings":["Rabin Medical Center, Petah Tiqva, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rabin Medical Center, Petah Tiqva, Israel","institution_ids":["https://openalex.org/I2800389475"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001068881","display_name":"Martin H. Kropff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I22465464","display_name":"University of M\u00fcnster","ror":"https://ror.org/00pd74e08","country_code":"DE","type":"education","lineage":["https://openalex.org/I22465464"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin Kropff","raw_affiliation_strings":["University of M\u00fcnster, M\u00fcnster, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of M\u00fcnster, M\u00fcnster, Germany;","institution_ids":["https://openalex.org/I22465464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029726728","display_name":"Alain Kentos","orcid":"https://orcid.org/0000-0003-1255-867X","observed_orcids":["https://orcid.org/0000-0003-1255-867X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alain Kentos","raw_affiliation_strings":["Belgian Myeloma Study Group, Brussels, Belgium;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgian Myeloma Study Group, Brussels, Belgium;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071926851","display_name":"Mich\u00e8le Cavo","orcid":"https://orcid.org/0000-0003-4514-3227","observed_orcids":["https://orcid.org/0000-0003-4514-3227"]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michele Cavo","raw_affiliation_strings":["Institute of Hematology and Medical Oncology \u201cSer\u00e0gnoli,\u201d University of Bologna, Bologna, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Hematology and Medical Oncology \u201cSer\u00e0gnoli,\u201d University of Bologna, Bologna, Italy;","institution_ids":["https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025908450","display_name":"Anatoly K. Golenkov","orcid":"https://orcid.org/0000-0002-6523-9157","observed_orcids":["https://orcid.org/0000-0002-6523-9157"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anatoly Golenkov","raw_affiliation_strings":["Moscow Region Clinical Institute, Moscow, Russia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moscow Region Clinical Institute, Moscow, Russia;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075621971","display_name":"Mieczys\u0142aw A. Komarnicki","orcid":"https://orcid.org/0000-0001-6833-0709","observed_orcids":["https://orcid.org/0000-0001-6833-0709"]},"institutions":[{"id":"https://openalex.org/I120230055","display_name":"Poznan University of Medical Sciences","ror":"https://ror.org/02zbb2597","country_code":"PL","type":"education","lineage":["https://openalex.org/I120230055"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mieczyslaw Komarnicki","raw_affiliation_strings":["Department of Hematology, University of Medical Sciences, Poznan, Poland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University of Medical Sciences, Poznan, Poland;","institution_ids":["https://openalex.org/I120230055"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029159537","display_name":"Mar\u00eda\u2010Victoria Mateos","orcid":"https://orcid.org/0000-0003-2390-1218","observed_orcids":["https://orcid.org/0000-0003-2390-1218"]},"institutions":[{"id":"https://openalex.org/I134820265","display_name":"Consejo Superior de Investigaciones Cient\u00edficas","ror":"https://ror.org/02gfc7t72","country_code":"ES","type":"government","lineage":["https://openalex.org/I134820265"]},{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210138819","display_name":"Centro de Investigaci\u00f3n del C\u00e1ncer","ror":"https://ror.org/04rxrdv16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4210138819"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maria-Victoria Mateos","raw_affiliation_strings":["Hospital Universitario Salamanca, CIC, IBMCC (USAL-CSIC), Salamanca, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Salamanca, CIC, IBMCC (USAL-CSIC), Salamanca, Spain;","institution_ids":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4210138819"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090790045","display_name":"Dixie-Lee W. Esseltine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dixie-Lee Esseltine","raw_affiliation_strings":["Millennium Pharmaceuticals Inc. (Cambridge, MA)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals Inc. (Cambridge, MA)","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110879335","display_name":"Andrew Cakana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140598","display_name":"Johnson & Johnson (United Kingdom)","ror":"https://ror.org/03qwpn290","country_code":"GB","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210140598"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrew Cakana","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research & Development, High Wycombe, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research & Development, High Wycombe, United Kingdom;","institution_ids":["https://openalex.org/I4210140598"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kevin Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kevin Liu","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research & Development LLC, Raritan, NJ; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research & Development LLC, Raritan, NJ; and","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087353636","display_name":"William M Deraedt","orcid":"https://orcid.org/0000-0003-1414-2387","observed_orcids":["https://orcid.org/0000-0003-1414-2387"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"William Deraedt","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research & Development, Beerse, Belgium","Johnson & Johnson Pharmaceutical Research and Development, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research & Development, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research and Development, Beerse, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049970120","display_name":"Helgi J. Van de Velde","orcid":"https://orcid.org/0009-0004-4126-8289","observed_orcids":["https://orcid.org/0009-0004-4126-8289"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Helgi van de Velde","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research & Development, Beerse, Belgium","Johnson & Johnson Pharmaceutical Research and Development, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research & Development, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]},{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research and Development, Beerse, Belgium","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020989412","display_name":"Jes\u00fas F. San Miguel","orcid":"https://orcid.org/0000-0002-9183-4857","observed_orcids":["https://orcid.org/0000-0002-9183-4857"]},"institutions":[{"id":"https://openalex.org/I134820265","display_name":"Consejo Superior de Investigaciones Cient\u00edficas","ror":"https://ror.org/02gfc7t72","country_code":"ES","type":"government","lineage":["https://openalex.org/I134820265"]},{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210138819","display_name":"Centro de Investigaci\u00f3n del C\u00e1ncer","ror":"https://ror.org/04rxrdv16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4210138819"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jes\u00fas F. San Miguel","raw_affiliation_strings":["Hospital Universitario Salamanca, CIC, IBMCC (USAL-CSIC), Salamanca, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Salamanca, CIC, IBMCC (USAL-CSIC), Salamanca, Spain;","institution_ids":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4210138819"]}]}],"institutions":[],"countries_distinct_count":9,"institutions_distinct_count":14,"corresponding_author_ids":["https://openalex.org/A5110474614"],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":8.1984,"has_fulltext":true,"cited_by_count":115,"citation_normalized_percentile":{"value":0.98031367,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"116","issue":"19","first_page":"3743","last_page":"3750"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9589999914169312},{"id":"https://openalex.org/keywords/newly-diagnosed-multiple-myeloma","display_name":"newly diagnosed multiple myeloma","score":0.9039999842643738},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.8560000061988831},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9559999704360962},{"id":"https://openalex.org/keywords/melphalan-and-prednisone","display_name":"melphalan-prednisone","score":0.921999990940094},{"id":"https://openalex.org/keywords/vista-trial","display_name":"VISTA trial","score":0.7160000205039978},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7749999761581421},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.9269999861717224},{"id":"https://openalex.org/keywords/time-to-next-therapy","display_name":"time to next therapy","score":0.8899999856948853},{"id":"https://openalex.org/keywords/treatment-free-interval","display_name":"treatment-free interval","score":0.9929999709129333},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6819999814033508},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.5590000152587891}],"concepts":[{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.8788130283355713},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.8456989526748657},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8345744609832764},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.7359285950660706},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6724398732185364},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.5720404982566833},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5250492095947266},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47965291142463684},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.43667131662368774},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.4241967499256134},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4118896424770355},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3989697992801666},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.26686373353004456}],"mesh":[{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001897","descriptor_name":"Boronic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008558","descriptor_name":"Melphalan","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1182/blood-2010-03-275800","doi":"https://doi.org/10.1182/blood-2010-03-275800","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2010-03-275800","pdf_url":"https://ashpublications.org/blood/article-pdf/116/19/3743/1489251/zh804510003743.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:20628153","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20628153","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:iris.unito.it:2318/88335","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2318/88335","pdf_url":"https://iris.unito.it/bitstream/2318/88335/1/755042.pdf","source":{"id":"https://openalex.org/S4306400637","display_name":"Institutional Research Information System University of Turin (University of Turin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I55143463","host_organization_name":"University of Turin","host_organization_lineage":["https://openalex.org/I55143463"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:cris.unibo.it:11585/100273","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11585/100273","pdf_url":null,"source":{"id":"https://openalex.org/S4306402579","display_name":"Archivio istituzionale della ricerca (Alma Mater Studiorum Universit\u00e0 di Bologna)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210117483","host_organization_name":"Istituto di Ematologia di Bologna","host_organization_lineage":["https://openalex.org/I4210117483"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:digital.csic.es:10261/63102","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10261/63102","pdf_url":null,"source":{"id":"https://openalex.org/S4306400616","display_name":"DIGITAL.CSIC (Spanish National Research Council (CSIC))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I134820265","host_organization_name":"Consejo Superior de Investigaciones Cient\u00edficas","host_organization_lineage":["https://openalex.org/I134820265"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Art\u00edculo"}],"best_oa_location":{"id":"doi:10.1182/blood-2010-03-275800","doi":"https://doi.org/10.1182/blood-2010-03-275800","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2010-03-275800","pdf_url":"https://ashpublications.org/blood/article-pdf/116/19/3743/1489251/zh804510003743.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320333265","display_name":"Takeda Oncology","ror":"https://ror.org/05vm7p871"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2062373072.pdf","grobid_xml":"https://content.openalex.org/works/W2062373072.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W1914496726","https://openalex.org/W1978377409","https://openalex.org/W1978833579","https://openalex.org/W1982499121","https://openalex.org/W1983597383","https://openalex.org/W1990372450","https://openalex.org/W1991660588","https://openalex.org/W1999549312","https://openalex.org/W2012843756","https://openalex.org/W2016038211","https://openalex.org/W2019612632","https://openalex.org/W2028150271","https://openalex.org/W2044436186","https://openalex.org/W2056206654","https://openalex.org/W2066108041","https://openalex.org/W2066295909","https://openalex.org/W2066800926","https://openalex.org/W2076028786","https://openalex.org/W2089294472","https://openalex.org/W2096207943","https://openalex.org/W2096909309","https://openalex.org/W2102591890","https://openalex.org/W2103289287","https://openalex.org/W2108235071","https://openalex.org/W2111650326","https://openalex.org/W2132155854","https://openalex.org/W2134592456","https://openalex.org/W2136256331","https://openalex.org/W2140359211","https://openalex.org/W2148758597","https://openalex.org/W2150254829","https://openalex.org/W2151512626","https://openalex.org/W2153596485","https://openalex.org/W2160635879","https://openalex.org/W2163129932","https://openalex.org/W2163941973","https://openalex.org/W2313913420","https://openalex.org/W2333363976","https://openalex.org/W2412441094","https://openalex.org/W2524582978","https://openalex.org/W2547194241","https://openalex.org/W2584457840","https://openalex.org/W2750956955","https://openalex.org/W4211082074","https://openalex.org/W4236730981"],"related_works":["https://openalex.org/W2524582978","https://openalex.org/W2103289287","https://openalex.org/W2547188540","https://openalex.org/W2750956955","https://openalex.org/W2461628621","https://openalex.org/W2592309712","https://openalex.org/W1978833579","https://openalex.org/W2942584148","https://openalex.org/W2163129932","https://openalex.org/W2554414226"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2062373072","counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
